Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Genome Analysis Shows Meiosis Gene Mutation Causes Primary Ovarian Insufficiency

By LabMedica International staff writers
Posted on 28 Dec 2014
A mutation in a gene linked to the process of meiosis was found in two sisters diagnosed with primary ovarian insufficiency (POI), a syndrome that prevented them from reaching sexual maturity.

Mammals and many other organisms achieve reduction and recombination through a process called meiosis, which is recognizable by the presence of a distinctive structure—the synaptonemal complex (SCS), —that links the chromosomes together and is essential for meiosis to complete. More...
The protein encoded by the SYCE1 gene (synaptonemal complex central element 1) may have a role in the synaptonemal complex assembly, stabilization, and recombination. Genes involved in essential steps in chromosome synapsis and recombinations during meiosis, such as SYCE1, have been shown to cause POI in animal models but not in humans.

Investigators at Tel Aviv University (Israel) worked with two daughters of consanguineous parents (first cousins) from a 13-member Israeli-Arab family who had been diagnosed with POI. Genotyping was performed in the patients, their parents, four unaffected siblings, and a group of 90 ethnically matched control individuals.

DNA from the affected sisters was subjected to whole-exome sequencing. The genotypes of interest were confirmed, and genotypes of the additional family members and the control subjects were determined by Sanger sequencing.

Results revealed a nonsense homozygous mutation in the SYCE1 gene in both affected sisters. The parents and three brothers were heterozygous for the mutation, and an unaffected sister did not carry the mutation. The mutation was not identified in the DNA samples from the 90 control subjects.

"One of my main topics of interest is puberty," said first author Dr. Liat de Vries, professor of medicine at Tel Aviv University. "The clinical presentation of the 2 sisters, out of 11 children of first-degree cousins, was interesting. In each of the girls, POI was expressed differently. One had reached puberty and was almost fully developed but did not have menses. The second, 16 years old, showed no signs of development whatsoever. By identifying the genetic mutation, we saved the family a lot of heartache by presenting evidence that any chance of inducing fertility in these two girls is slight. As bad as the news is, at least they will not spend years on fertility treatments and will instead invest efforts in acquiring an egg donation, for example. Knowledge is half the battle—and now the entire family knows it should undergo genetic testing for this mutation."

The paper was published in the July 25, 2014, online edition of the Journal of Clinical Endocrinology and Metabolism.

Related Links:
Tel Aviv University



Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.